TY - JOUR
T1 - Safety and Feasibility of Same-Day Discharge After Left Atrial Appendage Closure
AU - Gilhofer, Thomas S.
AU - Inohara, Taku
AU - Parsa, Ashkan
AU - Walker, Minette
AU - Uchida, Naomi
AU - Tsang, Michael
AU - Saw, Jacqueline
N1 - Funding Information:
J.S. has received unrestricted research grant support from the Canadian Institutes of Health Research (Canada), Heart and Stroke Foundation of Canada , National Institutes of Health (USA), AstraZeneca (UK), Abbott Vascular (USA), St Jude Medical (USA), Boston Scientific (USA), and Servier (France), salary support from the Michael Smith Foundation for Health Research (Canada), speaker honoraria from AstraZeneca , Abbott Vascular , Boston Scientific , and Bayer (Germany), consultancy and advisory board honoraria from AstraZeneca , Boston Scientific , Abbott Vascular , Gore (USA), and Abiomed (USA), and proctorship honoraria from Abbott Vascular and Boston Scientific . The other authors have no conflicts of interest to disclose.
Publisher Copyright:
© 2020 Canadian Cardiovascular Society
PY - 2020/6
Y1 - 2020/6
N2 - Subacute or late complications > 24 hours after left atrial appendage closure (LAAC) are infrequent. We therefore created a clinical pathway to enable safe same-day discharge (SDD) after LAAC. Patients were assessed for overall physical conditioning, lack of significant frailty and comorbidities limiting physical abilities, good home support, and patient preference. Of 78 LAACs performed, 24 patients (30.8%) were discharged the same day: 21 were transesophageal echocardiography guided and 3 intracardiac echocardiography guided. SDD clinical pathway patients were discharged 395.4 ± 56.6 minutes after leaving the procedural room. There were no clinical complications at 1 month or in long-term follow-up. SDD is safe and feasible after LAAC, following a dedicated clinical pathway and surveillance in carefully selected patients.
AB - Subacute or late complications > 24 hours after left atrial appendage closure (LAAC) are infrequent. We therefore created a clinical pathway to enable safe same-day discharge (SDD) after LAAC. Patients were assessed for overall physical conditioning, lack of significant frailty and comorbidities limiting physical abilities, good home support, and patient preference. Of 78 LAACs performed, 24 patients (30.8%) were discharged the same day: 21 were transesophageal echocardiography guided and 3 intracardiac echocardiography guided. SDD clinical pathway patients were discharged 395.4 ± 56.6 minutes after leaving the procedural room. There were no clinical complications at 1 month or in long-term follow-up. SDD is safe and feasible after LAAC, following a dedicated clinical pathway and surveillance in carefully selected patients.
UR - http://www.scopus.com/inward/record.url?scp=85086532606&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086532606&partnerID=8YFLogxK
U2 - 10.1016/j.cjca.2020.02.069
DO - 10.1016/j.cjca.2020.02.069
M3 - Article
C2 - 32536375
AN - SCOPUS:85086532606
SN - 0828-282X
VL - 36
SP - 945
EP - 947
JO - Canadian Journal of Cardiology
JF - Canadian Journal of Cardiology
IS - 6
ER -